Word

LYCIA THERAPEUTICS

Status

Pending

Status Code

732

Status Date

Friday, February 2, 2024

Serial Number

90672001

Mark Type

4000

Filing Date

Monday, April 26, 2021

Published for Opposition

Tuesday, July 26, 2022

Trademark Owner History

Lycia Therapeutics, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations comprising small molecules and antibodies for degrading disease-causing cellular proteins for treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Biological preparations for the prevention and treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Gene therapy products, namely, biological preparations for the treatment of cancer, autoimmune diseases, immunologic-based diseases and other human diseases, in particular, neurological disorders and conditions; Pharmaceutical preparations for use in gene therapy; Biological preparations for use in gene therapy; Viruses for therapeutic purposes, namely, for gene therapy and antivirals

"THERAPEUTICS"

Trademark Events

Feb 6, 2024

Notice Of Approval Of Extension Request E-Mailed

Feb 2, 2024

Sou Extension 3 Granted

Feb 2, 2024

Sou Extension 3 Filed

Feb 2, 2024

Sou Teas Extension Received

Aug 19, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 17, 2023

Sou Extension 2 Granted

Aug 17, 2023

Sou Extension 2 Filed

Aug 17, 2023

Sou Teas Extension Received

Jan 26, 2023

Notice Of Approval Of Extension Request E-Mailed

Jan 24, 2023

Sou Extension 1 Granted

Jan 24, 2023

Sou Extension 1 Filed

Jan 24, 2023

Sou Teas Extension Received

Sep 20, 2022

Noa E-Mailed - Sou Required From Applicant

Jul 26, 2022

Official Gazette Publication Confirmation E-Mailed

Jul 26, 2022

Published For Opposition

Jul 6, 2022

Notification Of Notice Of Publication E-Mailed

Jun 17, 2022

Approved For Pub - Principal Register

Jun 16, 2022

Teas/Email Correspondence Entered

Jun 16, 2022

Correspondence Received In Law Office

Jun 16, 2022

Teas Response To Office Action Received

Dec 22, 2021

Notification Of Non-Final Action E-Mailed

Dec 22, 2021

Non-Final Action E-Mailed

Dec 22, 2021

Non-Final Action Written

Dec 21, 2021

Assigned To Examiner

Jul 31, 2021

New Application Office Supplied Data Entered

Apr 29, 2021

New Application Entered